Funding
Funding not disclosed
Founders
Product
Problem
Many women lack convenient and accessible methods for understanding their fertility status and planning for future family needs. Traditional fertility assessments often require in-person visits to clinics, which can be time-consuming, costly, and geographically limiting. This lack of accessible information can lead to delayed family planning or missed opportunities for proactive fertility management.
Solution
Arva Fertility provides at-home fertility hormone tests for women, coupled with personalized analysis and expert consultations, to proactively inform family planning. The company offers a comprehensive blood test, performed at home via a mobile phlebotomist, that analyzes 11 key hormones related to ovarian reserve, thyroid health, and other reproductive factors. Results are delivered via a detailed report, accompanied by a consultation with a fertility advisor to interpret the findings and discuss potential next steps, such as fertility optimization or egg freezing. Arva aims to empower women with data-driven insights into their reproductive health, enabling them to make informed decisions about their fertility journey.
Target Audience
Arva Fertility primarily targets women in India who are curious about their fertility, planning for pregnancy, or considering options for future family building, including egg freezing.
Features
- At-home blood tests conducted by certified phlebotomists, eliminating the need for clinic visits
- Comprehensive hormone analysis, measuring up to 11 key fertility markers, including AMH, FSH, and thyroid hormones
- Personalized fertility analysis reports with clear, actionable insights
- Consultations with fertility advisors to interpret test results and discuss family planning options
- Access to a supportive online community for shared experiences and peer support
- Option for a simpler Egg Count (AMH-only) test for a quick assessment of ovarian reserve
- Digital reports delivered within 48-72 hours